VOI - Voice of Indonesia | RRI - Radio Republik Indonesia

photo : ayosemarang

Indonesia is upbeat about mass-producing domestically made COVID-19 vaccine by mid-2021, Dr. Reisa Broto Asmoro of the Task Force for Acceleration of COVID-19 Response (GTPP) stated in Jakarta on Tuesday (July7). Dr. Reisa also said, the vaccine would be prioritized for populations at the highest risk, specifically elderly or those with existing comorbidity. Community groups that fall into this category need to be safeguarded from the COVID-19 pandemic. Indonesia would not be singlehandedly endeavoring to manufacture the vaccine but will collaborate with a South Korean company. Moreover she said of the 15 stages that should necessarily be cleared, the domestically-made candidate vaccines had succeeded in passing eight stages. The subsequent seven stages would require quite a long time to clear. Although Indonesia is currently striving to create a COVID-19 vaccine, she affirmed that vaccines manufactured in other countries were also required to boost the immunity of people in the country//ant